Oral Session 1-11C MDS: Basic (1)

[OS1-11C-2] NUP98-HBO1 induces clinically relevant CMML pathogenesis through aberrant histone acetylation

Yoshihiro Hayashi¹, Yuka Harada², Yuki Kagiyama¹, Ye Ding³, Jun Imagawa⁴, Naoki Shingai⁵, Naoko Kato⁶, Jiro Kitaura⁷, Norio Komatsu⁵, Hirotaka Matsui⁸, Issay Kitabayashi⁹, Atsushi Iwama¹⁰, Toshio Kitamura⁶, Hironori Harada¹ (1.Lab. Oncology, Tokyo University of Pharmacy & Life Sciences, Tokyo, Japan, 2.Dept. Clinical Laboratory Medicine, Bunkyo Gakuin University, Tokyo, Japan, 3.Div. Oncology and Hematology, Edogawa Hospital, Tokyo, Japan, 4.Dept. Hematology and Oncology, Hiroshima University, Hiroshima, Japan, 5.Dept. Hematology, Juntendo University, Tokyo, Japan, 6.Div. Cellular Therapy, IMS, the University of Tokyo, Tokyo, Japan, 7.Atopy Research Center, Juntendo University, Tokyo, Japan, 8.Dept. Molecular Laboratory Medicine, Kumamoto University, Kumamoto, Japan, 9.Div. Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan, 10.Dept. Cellular and Molecular Medicine, Chiba University, Chiba, Japan)